Drreddys Laboratories reported $278.5B in Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Ani Pharmaceuticals ANIP:US $ 744.85M 26.75M
Aurora Cannabis Inc ACB:CN 1.57B 915.13M
Bayer BAYN:GR € 125782M 5541M
Canopy Growth Corp WEED:CN C$ 5.62B 693.98M
Catalent CTLT:US $ 10322M 119M
Corcept Therapeutics CORT:US $ 468.12M 44.37M
Endo International Ordinary Shares ENDP:US $ 8447.21M 320.2M
GlaxoSmithKline GSK:LN 89689M 10586M
Hikma Pharmaceutical HIK:LN 4.37B 192M
Horizon Pharma HZNP:US $ 8740.34M 62.61M
JAZZ PHA JAZZ:US $ 11768.92M 529.72M
Lannett LCI:US $ 572.31M 22.63M
Lonza Group LONN:SW 16.46B 1.3B
Novartis NOVN:VX SF 125218M 6577M
Pacira Pharmaceuticals PCRX:US $ 1891.48M 183.88M
Phibro Animal Health PAHC:US $ 916.18M 67.22M
Prestige Brands PBH:US $ 3670.68M 11.27M
Richter Gedeon RICHT:HB 1174.15B 28.86B
Supernus Pharmaceuticals SUPN:US $ 1639.52M 49.64M
Teva Pharmaceutical TEVA:IT 47.06B 607M